欢迎登录材料期刊网

材料期刊网

高级检索

纳米羟基磷灰石(n-HAP)独特的表面晶体结构可使其对药物产生选择性吸附,而不同的孔结构则可有效控制载药量和释药速率,同时,良好的生物活性使其在骨疾病治疗过程中显示着重要的骨诱导作用.分析讨论了n-HAP作为药物载体材料的研究现状及工艺技术,探讨了其与高分子材料复合后对药物缓释性能的影响,指出了n-HAP粒子作为药物载体的发展趋势及存在的主要问题.

参考文献

[1] Younghoon Kim;Paul Dalhaimer;David A Christian .Polymeric worm micelles as nano-carriers for drug delivery[J].Nanotechnology,2005(7):S484-S491.
[2] Prabaharan M;Gong S Q .Novel thiolated carboxymethyl chitosan-g-β-cyclodextrin as mucoadhesive hydrophobic drugdelivery carriers[J].Carbohydrate Polymers,2008,73(01):117.
[3] Hench L L .Bioceramics:From concept to clinic[J].Journal of the American Ceramic Society,1991,74(07):1487.
[4] 王志新,刘莹,杨晓民,赵旭,孔祥波.纳米羟基磷灰石对人源性泌尿系肿瘤细胞增殖的影响[J].中国老年学杂志,2007(23):2276-2277.
[5] 陈晓娟,李小平,唐忠志,刘非凡.羟基磷灰石纳米粒子对人胃癌细胞增殖及侵袭的影响[J].实用医学杂志,2009(19):3181-3183.
[6] 陈庆榆,朱融融,张蕤,田川,孙晓宇,汪世龙.纳米羟基磷灰石对两种药物的载药性能研究[J].复旦学报(自然科学版),2009(03):386-390.
[7] Almora-Batrios N;Austen K F;de Leeuw N H .Density functional theory study of the binding of glycine,proline,and hydroxyproline to the hydroxyapatite (0001) and (0110) surfaces[J].Langmuir,2009,25(09):5018.
[8] Albert Rimola;Marta Corno;Claudio Marcelo Zicovich-Wilson;Piero Ugliengo .Ab Initio Modeling of Protein/Biomaterial Interactions: Glycine Adsorption at Hydroxyapatite Surfaces[J].Journal of the American Chemical Society,2008(48):16181-16183.
[9] 庞晓峰,曾红娟.纳米羟基磷灰石粉体的生物活性的研究[J].材料工程,2009(04):14-17,22.
[10] 滕利荣,王博,刘艳,王春艳,孟庆繁,高波.羟基磷灰石纳米粒子作为蛋白类缓释药物载体的应用[J].吉林大学学报(工学版),2007(05):1093-1096.
[11] 肖凤娟,张颖,王少辉,高峻峰.硅掺杂羟基磷灰石生物活性微粉对人血清白蛋白的吸附特性[J].复合材料学报,2009(02):149-154.
[12] 林英光,杨卓如,程江.纳米掺锶羟基磷灰石的制备及其吸附性能研究[J].化学与生物工程,2006(12):13-15,21.
[13] Dasgupta, S;Banerjee, SS;Bandyopadhyay, A;Bose, S .Zn- and Mg-Doped Hydroxyapatite Nanoparticles for Controlled Release of Protein[J].Langmuir: The ACS Journal of Surfaces and Colloids,2010(7):4958-4964.
[14] Zhang C;Li C;Huang .Self-activated luminescent and mesoporous strontium hydroxyapatite nanorods for drug delivery.[J].Biomaterials,2010(12):3374-3383.
[15] Ishihara S;Matsumoto T;Onoki T;Uddin MH;Sohmura T;Nakahira A .Regulation of the protein-loading capacity of hydroxyapatite by mercaptosuccinic acid modification.[J].Acta biomaterialia,2010(3):830-835.
[16] 刘安琪,陈建峰,李雪光,程鹏,文利雄.空心多孔纳米载体负载药物的药量分布研究[J].高校化学工程学报,2007(05):832-837.
[17] 徐惠,张斯凡,刘小育,苟国俊.水热合成微孔纳米羟基磷灰石[J].应用化学,2008(11):1255-1258.
[18] 樊国栋,陈春兰,张春梅,王强.纳米羟基磷灰石的合成工艺研究[J].无机盐工业,2010(02):15-17.
[19] Kim IS;Kumta PN .Sol-gel synthesis and characterization of nanostructured hydroxyapatite powder[J].Materials Science & Engineering, B. Solid-State Materials for Advanced Technology,2004(2/3):232-236.
[20] Hae-Hyoung Lee;Seok-Jung Hong;Chul-Hwan Kim;Eun-Cheol Kim;Jun-Hyeog Jang;Hong-In Shin;Hae-Won Kim .Preparation of hydroxyapatite spheres with an internal cavity as a scaffold for hard tissue regeneration[J].Journal of Materials Science. Materials in Medicine,2008(9):3029-3034.
[21] Tomoda, K;Ariizumi, H;Nakaji, T;Makino, K .Hydroxyapatite particles as drug carriers for proteins[J].Colloids and Surfaces, B. Biointerfaces,2010(1):226-235.
[22] Wang, Y.;Hassan, M.S.;Gunawan, P.;Lau, R.;Wang, X.;Xu, R. .Polyelectrolyte mediated formation of hydroxyapatite microspheres of controlled size and hierarchical structure[J].Journal of Colloid and Interface Science,2009(1):69-77.
[23] Zhao, YF;Ma, J .Triblock co-polymer templating synthesis of mesostructured hydroxyapatite[J].Microporous and Mesoporous Materials,2005(2):110-117.
[24] Ye F;Guo H;Zhang H;He X .Polymeric micelle-templated synthesis of hydroxyapatite hollow nanoparticles for a drug delivery system.[J].Acta biomaterialia,2010(6):2212-2218.
[25] He Q J;Huang Z L;Liu Y et al.Template-directed onestep synthesis of flowerlike porous carbonated hydroxyapatite spheres[J].Materials Letters,2007,61(01):141.
[26] Cheng, XK;He, QJ;Li, JQ;Huang, ZL;Chi, RA .Control of Pore Size of the Bubble-Template Porous Carbonated Hydroxyapatite Microsphere by Adjustable Pressure[J].Crystal growth & design,2009(6):2770-2775.
[27] Cheng, XK;Huang, ZL;Li, JQ;Liu, Y;Chen, CL;Chi, RA;Hu, YH .Self-Assembled Growth and Pore Size Control of the Bubble-Template Porous Carbonated Hydroxyapatite Microsphere[J].Crystal growth & design,2010(3):1180-1188.
[28] Strength of hollow hydroxyapatite microspheres prepared by a glass conversion process[J].Journal of Materials Science. Materials in Medicine,2009(1):123.
[29] Guo Y P;Zhou Y;Jia D C et al.Me,porous structure and evolution mechanism of hydroxycarbonate apatite microspheres[J].Materials Science and Engineering C:Biomimetic and Supramolecular Systems,2010,30(03):472.
[30] Melville AJ;Rodriguez-Lorenzo LM;Forsythe JS .Effects of calcination temperature on the drug delivery behaviour of Ibuprofen from hydroxyapatite powders[J].Journal of Materials Science. Materials in Medicine,2008(3):1187-1195.
[31] De Geest, BG;De Koker, S;Demeester, J;De Smedt, SC;Hennink, WE .Pulsed in vitro release and in vivo behavior of exploding microcapsules[J].Journal of Controlled Release: Official Journal of the Controlled Release Society,2009(3):268-273.
[32] Shi X;Wang Y;Ren L;Gong Y;Wang DA .Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications.[J].Pharmaceutical research,2009(2):422-430.
[33] Ho ML;Fu YC;Wang GJ;Chen HT;Chang JK;Tsai TH;Wang CK .Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite[J].Journal of Controlled Release: Official Journal of the Controlled Release Society,2008(2):142-148.
[34] Liu TY;Chen SY;Liu DM;Liou SC .On the study of BSA-loaded calcium-deficient hydroxyapatite nano-carriers for controlled drug delivery[J].Journal of Controlled Release: Official Journal of the Controlled Release Society,2005(1):112-121.
[35] Morita T;Horikiri Y;Suzuki T;Yoshino H .Applicability of various amphiphilic polymers to the modification of protein release kinetics from biodegradable reservoir-type microspheres.[J].European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V,2001(1):45-53.
[36] Makino K;Mngi T;Ohtake N et al.Pulsatile drug release from poly(lactide-co-glycolide) microspheres:How does the composition of the polymer matrixes affect the time interval between the initial burst and the pulsatile release of drugs[J].Colloids and Surfaces B:Biointerfaces,2000,19(02):173.
[37] 李峻峰,张利,左奕,邹琴,付莉,李玉宝.CS/n-HA复合微球的制备与表征[J].功能材料,2009(04):653-655.
[38] Wei Huang;Yingjun Wang;Li Ren;Chang Du;Xuetao Shi .A novel PHBV/HA microsphere releasing system loaded with alendronate[J].Materials science & engineering, C. Biomimetic and supramolecular systems,2009(7):2221-2225.
[39] Zhang J;Wang Q;Wang A .In situ generation of sodium alginate/hydroxyapatite nanocomposite beads as drug-controlled release matrices.[J].Acta biomaterialia,2010(2):445-454.
上一张 下一张
上一张 下一张
计量
  • 下载量()
  • 访问量()
文章评分
  • 您的评分:
  • 1
    0%
  • 2
    0%
  • 3
    0%
  • 4
    0%
  • 5
    0%